BridgeBio Pharma, Inc. — DEFA14A Filings
6 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 6 DEFA14A documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001140361-25-018190 | May 9, 2025 | — |
| DEFA14A | DEFA14A | 0001140361-25-016655 | Apr 30, 2025 | — |
| DEFA14A | DEFA14A | 0001140361-24-022031 | Apr 25, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-127322 | Apr 28, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-133655 | Apr 29, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-20-117295 | Apr 23, 2020 | — |